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Reply to the Editor:
This letter is to acknowledge the rheuma-
tologic comments and queries by Juna re-
garding our recently published case re-
ports1,2 of aortic dissection without Marfan
syndrome in ankylosing spondylitis. In re-
gard to the second case,2 Juna asked us
whether other complementary explorations,
such as computed tomography scanning,
magnetic resonance imaging, or radionuclide
imaging, were practiced to obtain the diag-
nosis of sacroiliitis. We practiced computed
tomography scanning (Figure 1), not mag-
netic resonance imaging and radionuclide
imaging, which demonstrated relatively
apparent sacroiliitis, not typical ankylosis
in the sacroiliac joints, despite no evident
sacroiliitis on the abdominal radiography in
the figure of the second case report. To be
accurate, however, the diagnosis of the 2
cases might not be ankylosing spondylitis
itself but spondyloarthropathies, which
consist of ankylosing spondylitis, psoriatic
arthritis, reactive arthritis, inflammatory
bowel disease-related arthritis, and undif-
ferentiated spondyloarthropathy, because
the patients met only the European Spon-
dyloarthropathy Study Group criteria3 for
the classification of spondyloarthropathy.
In both cases, the diagnosis of psoriatic
arthritis, reactive arthritis, or inflammatory
bowel disease-related arthritis may be de-
nied because of the absence of psoriasis,
genitourinary or gastrointestinal infection,
or inflammatory bowel disease. Undiffer-
entiated spondyloarthropathy is one of the
probable diagnoses as mentioned by Juna,
because criteria might not be fulfilled for
any specific spondyloarthropathy in the
second patient. Even though the second
case is not ankylosing spondylitis but un-
differentiated spondyloarthropathy, there
have been no cases of aortic dissection in
undifferentiated spondyloarthropathy in the
literature except for our case.
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Implantable cardioverter-defibrillator
after left ventricular reconstruction?
To the Editor:
We read with great interest the article
by O’Neill and coworkers,1 which ad-
dresses an important question: Is implantable
cardioverter-defibrillator (ICD) implantation
indicated after left ventricular reconstruction
(LVR)?
The authors present their large experi-
ence of LVR as a nontransplant surgical
strategy for patients with heart failure, with
a focus on postoperative malignant arrhyth-
mias. Primary end points were all-cause
mortality and appropriate ICD therapies,
and median follow-up was 381 days. In
addition to the LVR, a small proportion of
patients (13%) received a specific antiar-
rhythmic surgical procedure consisting of
cryoablation, about half (46%) underwent a
mitral valve procedure, and most patients
(88%) were revascularized. The main find-
ings were that patients remain at high risk
of ventricular arrhythmias after LVR and
that the arrhythmias occur early postoper-
atively, in two thirds of the cases within 90
days. The authors recommend early ICD
implantation or electrophysiology (EP)–
guided ICD therapy before hospital dis-
charge after LVR.
We have 2 questions regarding the
study by O’Neill and coworkers1: (1) How
many patients had clinical arrhythmias be-
fore surgical intervention? (2) Were EP
studies conducted before surgical interven-
tion in any of the patients?
The answers to these questions are im-
portant to assess the effect of the procedure
per se on the incidence of postoperative
arrhythmias. There is some theoretic or in-
direct evidence that LVR promotes electri-
cal stability in the heart by different mech-
anisms.2Figure 1. Computed tomography of the second case.
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